Six arrests after nearly 250 children poisoned by lead in their food in China
Another 17 individuals are also "under disciplinary investigation", including the head of a local hospital, while 10 government officials have been held "accountable".
It comes after a scandal involving Heshi Peixin kindergarten in Maiji, northwestern China, emerged earlier this month.
Police said staff at the private kindergarten had been adding paint powder to food in an apparent bid to make it look more appealing.
Testing showed 247 out of 251 of the kindergarten's children and 28 members of staff had "abnormal blood levels".
A further five children who finished attending the kindergarten in 2024 also recorded abnormal levels of lead in their blood, according to investigators.
A Sky News team in Maiji had been accused of returning tests for lead showing much lower levels than at the bigger hospitals.
Investigators have now found the management of the Second People's Hospital of Tianshui was "chaotic" and its laboratory department had been illegally modifying the results of the blood lead tests.
The head of the hospital is one of the 17 people facing disciplinary investigation.
Sky News was told how one child was found to have lead in her blood at 38 times the normal level.
Read more from Sky News:
Lead poisoning at high levels can cause long term injuries to the brain and the central nervous system.
A mother who lived near the kindergarten said: "Now if people send children to primary school, the first thing they ask is are you safe?
"Can it guarantee the personal safety of our children in the future?"
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
WHO issues global warning as Chikungunya virus spreads in China
The mosquito-borne Chikungunya virus has recently begun to spread rapidly in southern China, the World Health Organization (WHO) announced on Wednesday. The organization is also warning of the disease's spread to other parts of the world. In the Chinese megacity of Foshan in Guangdong province, authorities have recorded 2,659 cases so far, Chinese state media reported. According to the report, 53 hospitals in the city with a total of more than 3,600 mosquito-proof beds have been designated for the treatment of the infectious disease. All cases reported so far have been mild. The WHO says the disease is already present in 119 countries. Theoretically, 5.6 billion people could be infected. The authorities recommend removing breeding grounds for mosquito larvae, such as flower pots, or killing the mosquitoes with chemical agents as a preventive measure. Long clothing also protects against bites. The tropical infectious disease is not usually fatal, but causes fever and severe joint and muscle pain. This is often accompanied by headaches and extreme exhaustion. The disease usually subsides after one to two weeks. However, the WHO says up to 40% of patients experience problems lasting months or years after infection. There was a Chikungunya epidemic in 2004 and 2005, which spread from small island states in the Indian Ocean to the rest of the world, affecting half a million people. The WHO says a similar pattern has been observed since the beginning of the year. Solve the daily Crossword
Yahoo
6 hours ago
- Yahoo
Americans Are Turning To DIY Weight Loss Injections to Dodge $1,000+ Monthly Drug Costs
Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance coverage has fueled a risky but growing 'gray' market for purchasing active ingredients from China, Reuters reported recently. Reuters cited a 44% monthly increase in January in shipments of tirzepatide and semaglutide from Chinese suppliers not registered with the U.S. Food and Drug Administration, according to data from the Partnership for Safe Medicines. The gray market — named because the drugs are technically legal to buy for 'research purposes' — provides users with GLP-1 compounds, including semaglutide, tirzepatide and even retatrutide, which is still in clinical trials, in powder form for as little as $50 a vial. Buyers then mix the powder with bacteriostatic water at home to create an injectable solution. Don't Miss: Deloitte's fastest-growing software company partners with Amazon, Walmart & Target – Many are rushing to grab $100k+ in investable assets? – no cost, no obligation. Without insurance, the monthly cost of these drugs starts at around $500 and can exceed $1,000. A survey by the International Foundation of Employee Benefit Plans found that 36% of employer health plans will cover GLP-1 drugs for obesity in 2025. In April, the Trump administration also announced that Medicare and Medicaid would not cover anti-obesity medications, which includes the GLP-1 class. Buyer Communities Try to Mitigrate Gray Market Risks However, the DIY gray market carries significant risks. Some buyers attempt to reduce these risks by sending powders to labs for purity testing before use. Janoshik Analytical CEO Peter Magic told Reuters that the Czech Republic-based lab tested 3,050 samples of obesity drugs in 2024, up from just over 650 the previous year. Yet the at-home mixing process still introduces human error. Amy Spencer, a Missouri woman interviewed by Reuters, said she reduced her monthly cost from more than $500 for brand-name GLP-1s to $50 on the gray market. But she accidentally overdosed after a reconstitution miscalculation, suffering severe flu-like symptoms for four days. Trending: This AI-Powered Trading Platform Has 5,000+ Users, 27 Pending Patents, and a $43.97M Valuation — FDA Ruling a Driving Factor to Going Gray If that level of risk sounds overwhelming to navigate, rest assured, passengers navigating the world of gray market peptides are hardly alone. Subreddits like "SemaglutideFreeSpeech" can provide some hand-holding, and also direct users to outside resources on more secretive channels, like Telegram. Many users on the subreddit are being directed to "go gray" after FDA rulings essentially halted the ability of compounding pharmacies to sell cheaper versions of the medicines. The FDA had temporarily allowed compounding of the GLP-1 drugs semaglutide and tirzepatide during shortages because federal law permits copycat versions when FDA-approved drugs are listed as scarce. When the shortages were resolved, however, the exemption ended — as did a cheaper alternative to brand-name GLP-1 drugs. Some compounders are trying to continue business as usual with workarounds like adding vitamin b12, to differentiate the medications from the FDA-approved Companies, State Attorneys Respond The gray market hasn't gone unnoticed by regulators and drug companies alike. Eli Lilly (NYSE:LLY), maker of GLP-1s Monjouro and Zepbound, and Novo Nordisk (NYSE:NVO) said they're combating unsafe products through lawsuits and consumer education, Reuters reports. Meanwhile on the customs front, the FDA does intercept some illegal imports, although personal-use buyers are rarely prosecuted. Attorneys general from 38 U.S. states and territories also warned the FDA in February about illegally sold weight-loss drugs, including unregulated ingredients from China, Reuters reports. 'It can be very dangerous. You're playing the role of your own doctor, pharmacist, and FDA inspector,' Shabbir Safdar, executive director of the Partnership for Safe Medicines, said in a statement to Reuters. Read Next: Many are using retirement income calculators to check if they're on pace — Image: Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? NOVO NORDISK (NVO): Free Stock Analysis Report ELI LILLY (LLY): Free Stock Analysis Report This article Americans Are Turning To DIY Weight Loss Injections to Dodge $1,000+ Monthly Drug Costs originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Fox News
10 hours ago
- Fox News
Is America Ready For War In The Indo-Pacific?
The President of the Philippines was at the White House on Tuesday visiting President Trump, discussing the issue of China and their ambitions to expand. U.S. lawmakers have asked the Defense Department to study building a joint munitions hub in the Philippines, as China continues to menace other nations crossing through the South China Sea. When it comes to American military spending, we are on track to allocate more than $920 billion in the next fiscal year, and it appears there's bipartisan support to fully fund this Pacific Deterrence Initiative. Florida Republican Senator Rick Scott sits on the Armed Services and Homeland Security Committee, and he joined the Rundown to discuss the long-term threats posed by both China and Iran. The CDC reports an estimated 48,422 deaths from synthetic opioids, mostly fentanyl, in 2024. With a dangerous amount of the drug supply now laced with this deadly substance, overdose deaths are surging, especially among young people. President Trump recently signed the Halt Fentanyl Act, expanding law enforcement's ability to crack down on traffickers. Gregory Swan, who lost his son Drew to a fentanyl overdose in 2013, co-founded Fentanyl Fathers to raise awareness and prevent more families from suffering the same loss. He joins the Rundown to discuss his mission: educating students, empowering parents, and mobilizing a movement to fight the fentanyl crisis. Plus, commentary from FOX News Digital columnist David Marcus. Photo Credit: AP Learn more about your ad choices. Visit
